Categories: News

TRxADE HEALTH, INC. to Report Fourth Quarter and Year End 2021 Financial Results on Monday, March 28th at 5:00 p.m. Eastern Time

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

TAMPA, FL / ACCESSWIRE / March 14, 2022 / TRxADE HEALTH INC. (NASDAQ:MEDS), is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S., will release financial results for the fourth quarter and Year End 2021, after market close on March 28, 2022. The financial results will be reported in a press release after the close of regular stock market trading hours on the same day as the conference call.

In addition, management will host a conference call on Monday, March 28, 2022, at 5:00 p.m. Eastern time to discuss TRxADE HEALTH’s fourth quarter and year end 2021 financial results. The call will conclude with a Q&A from participants. To participate, please use the following information:

Q4 2021 Conference Call and Webcast
Date: Monday, March 28, 2022
Time: 5:00 p.m. Eastern time
U.S. Dial-in: 1-877-425-9470
International Dial-in: 1-201-389-0878
Conference ID: 13727651
Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1534472&tp_key=20fddfb1b1

Please dial in at least 10 minutes before the start of the call to ensure timely participation.

A playback of the call will be available through April 28, 2022. To listen, call 1-844-512-2921 within the United States or 1-412-317-6671 when calling internationally and enter replay pin number 13727651. A webcast will also be available for 30 days on the IR section of the Trxade Group website or by clicking the webcast link above.

About TRxADE HEALTH, INC.
TRxADE HEALTH (NASDAQ:MEDS) is a health services IT company focused on digitalizing the retail pharmacy experience by optimizing drug procurement, the prescription journey and patient engagement in the U.S. The Company operates the TRxADE drug procurement marketplace serving a total of 12,700+ members nationwide, fostering price transparency and under the Bonum Health brand, offering patient centric telehealth services. For more information on TRxADE HEALTH, please visit the Company’s IR website at investors.trxadegroup.com.

Investor Relations:
IR@trxade.com
Investors.trxadegroup.com

SOURCE: TRxADE HEALTH, Inc.

View source version on accesswire.com:
https://www.accesswire.com/692827/TRxADE-HEALTH-INC-to-Report-Fourth-Quarter-and-Year-End-2021-Financial-Results-on-Monday-March-28th-at-500-pm-Eastern-Time

Staff

Recent Posts

Neural Therapeutics Announces SERFOR Permit Renewal Submission and Extension of LOI with HANF.COM

Toronto, Ontario--(Newsfile Corp. - May 9, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural"…

2 hours ago

SAB BIO Announces Q1 2025 Financial Results and Provides Company Updates

MIAMI, May 09, 2025 (GLOBE NEWSWIRE) -- SAB BIO (Nasdaq: SABS), (“SAB BIO” or the “Company”),…

2 hours ago

NEXGEL to Report First Quarter 2025 Financial Results on May 13th

Management will host a conference call at 4:30 P.M. ET on the same day LANGHORNE,…

2 hours ago

Outset Medical to Present at RBC Global Healthcare Conference

SAN JOSE, Calif., May 09, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”),…

2 hours ago

SRx Health Solutions Purchases $1.5 Million of Solana Tokens as Part of its Asset Allocation Diversification Strategy

TAMPA, Fla., May 09, 2025 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH)…

2 hours ago

Best Bodybuilding Supplements: Top Legal Steroids & Supplements For Bodybuilding & Muscle Growth

Backed by Wolfson Brands (UK) Limited, discover proven bodybuilding supplements & legal steroids that actually…

2 hours ago